Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating Solutions

Season 2, Episode 34,   Aug 22, 01:00 PM

In this episode, host Dr. Christina Madison interviews the co-CEOs of Healthcare Advocate Summit Melissa Paige, BPHM, CPhT, MTM, president of National Association of Medication Access & Patient Advocacy (NAMAPA), and Elizabeth Johnson, CEO of MedicoCX, and president and co-founder of NAMAPA on Healthcare Advocate Summit and its mission. They describe how collaboration, education, and advocacy can go a long way in improving access to medications and health care.

Key Takeaways:
  1. Medication Access: Medication access is a complex, systemic issue. The high cost of medication is a significant barrier for many patients, and navigating the health care system to obtain necessary medications can be confusing and overwhelming for many patients.
  2. Health Care Providers are Crucial in Improving Medication Access: Health care professionals can play a vital role in advocating for patients and assisting them in obtaining their prescribed medications. Understanding the complexities of medication access can empower health care providers to better support their patients.
  3. Patient Advocacy is Essential for Driving Change: Organizations and individuals dedicated to patient advocacy can create significant impact by raising awareness, lobbying for policy changes, and providing support to patients. Sharing personal stories can be a powerful tool for driving change in health care disparities.
  4. Collaboration and Education are Key: Partnerships between health care providers, patient advocacy groups, and policymakers are essential for addressing the medication access crisis. Educating patients, health care providers, and the public about medication access issues is crucial for creating lasting change.
You can learn more about Healthcare Advocate Summit and follow the initiative on social media:
Connect with Melissa Paige and Elizabeth Johnson on LinkedIn!
Subscribe
Next
Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development
Top episodes